Latest news
Phathom Pharmaceuticals, Inc. (PHAT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Sat, 08 Aug 2026 03:04:16 GMTPhathom’s Steve Basta Has Felt the Burn Himself - The Healthcare Technology Report.The Healthcare Technology Report. · Wed, 05 Aug 2026 12:05:37 GMTBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Phathom Pharmaceuticals, Inc. (PHAT) And Encourages Investors to Reach Out - ACCESS NewswireACCESS Newswire · Tue, 04 Aug 2026 21:47:46 GMTPHAT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Phathom Pharmaceuticals, Inc. (PHAT) - Business WireBusiness Wire · Mon, 03 Aug 2026 14:07:00 GMTWeekly Recap: Q2 revenue surge and Investigation into NASDAQ:PHAT guidance claim - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Phathom Pharmaceuticals, Inc. (PHAT) And Encourages Stockholders to Reach Out - ACCESS NewswireACCESS Newswire · Mon, 03 Aug 2026 11:13:08 GMTPhathom Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PHAT) 2026-08-01 - Seeking AlphaSeeking Alpha · Sat, 01 Aug 2026 23:24:12 GMTPhathom Pharmaceuticals (PHAT) Stock Slides Despite Cash Profit Breakthrough - simplywall.stsimplywall.st · Fri, 31 Jul 2026 23:34:06 GMT